Download PDF
Endoscopy 2005; 37(7): 667-673
DOI: 10.1055/s-2005-861464
Guidelines
© Georg Thieme Verlag KG Stuttgart · New York

Austrian Consensus on the Definition and Treatment of Portal Hypertension and its Complications

M.  Peck-Radosavljevic1 , M.  Trauner2 , F.  Schreiber2 (for the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
  • 1Medizinische Universität Wien, Klinik Innere Medizin IV, Abteilung Gastroenterologie und Hepatologie
  • 2Medizinische Universität Graz, Abteilung Gastroenterologie und Hepatologie
Further Information

Publication History

Publication Date:
11 July 2005 (online)

Also available at
    Permissions and Reprints

Introduction/Background

In November 2004, the Austrian Society of Gastroenterology and Hepatology (ÖGGH) held for the first time a consensus meeting on the definitions and treatment of portal hypertension and its complications in the Billroth-Haus in Vienna, Austria. This meeting was preceeded by an international experts meeting on portal hypertension with some of the proponents of the Baveno consensus conferences (www.oeggh.at/videos.asp). The consensus itself is based on the Baveno III consensus with regard to portal hypertensive bleeding [1] and the suggestions of the International Ascites Club regarding the treatment of ascites [2]. Those statements were modified by new knowledge derived from the recent literature and also by the current practice of medicine as agreed upon by the participants of the consensus meeting. The section on TIPS-placement was based on the consensus statement of the Vienna TIPS Study Group (VTSG) [3]

An effort was made to develop a practical guideline to everyday medical practice. In order to reduce the areas without specific recommendations for treatment to an absolute minimum, we tried to make suggestions for therapy even in case of insufficient or contradictory data through consensus of the participating physicians. The only area where we were not able to reach a consensus statement out of a variety of reasons was the treatment of the hepatorenal syndrome. This complication of portal hypertension was therefore not included into the consensus statement.

References

  • 1 de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.  J Hepatol. 2000;  33 846-852
    CrossrefPubMedGoogle Scholar
  • 2 Moore K P, Wong F, Gines P. et al . The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.  Hepatology. 2003;  38 258-266
    PubMedGoogle Scholar
  • 3 Angermayr B, Cejna M, Peck-Radosavljevic M. Management von Patienten vor und nach Implantation eines transjugulären intrahepatischen portosystemischen Shunts (TIPS) - Bericht der Vienna TIPS Study Group.  Journal für Gastroenterologische und Hepatologische Erkrankungen. 2003;  1 11-14
    PubMedGoogle Scholar
  • 4 Bosch J, Garcia-Pagan J C. Complications of cirrhosis. I. Portal hypertension.  J Hepatol. 2000;  32 141-156
    CrossrefPubMedGoogle Scholar
  • 5 D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach.  Semin Liver Dis. 1999;  19 475-505
    PubMedGoogle Scholar
  • 6 Merkel C, Bolognesi M, Sacerdoti D. et al . The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2000;  32 930-934
    CrossrefPubMedGoogle Scholar
  • 7 Abraldes J G, Tarantino I, Turnes J, Garcia-Pagan J C, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.  Hepatology. 2003;  37 902-908
    CrossrefPubMedGoogle Scholar
  • 8 Garcia-Pagan J C, Morillas R, Banares R. et al . Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.  Hepatology. 2003;  37 1260-1266
    CrossrefPubMedGoogle Scholar
  • 9 Schepke M, Kleber G, Nurnberg D. et al . Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2004;  40 65-72
    CrossrefPubMedGoogle Scholar
  • 10 Ben-Ari Z, Cardin F, McCormick A P, Wannamethee G, Burroughs A K. A predictive model for failure to control bleeding during acute variceal haemorrhage.  J Hepatol. 1999;  31 443-450
    CrossrefPubMedGoogle Scholar
  • 11 Bernard B, Grange J D, Khac E N, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.  Hepatology. 1999;  29 1655-1661
    CrossrefPubMedGoogle Scholar
  • 12 Moitinho E, Escorsell A, Bandi J C. et al . Prognostic value of early measurements of portal pressure in acute variceal bleeding.  Gastroenterology. 1999;  117 626-631
    CrossrefPubMedGoogle Scholar
  • 13 Bureau C, Peron J M, Alric L. et al . ”A La Carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.  Hepatology. 2002;  36 1361-1366
    CrossrefPubMedGoogle Scholar
  • 14 Cejna M, Peck-Radosavljevic M, Thurnher S. et al . ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.  Cardiovasc Intervent Radiol. 2002;  25 365-372
    CrossrefPubMedGoogle Scholar
  • 15 Angermayr B, Cejna M, Koenig F. et al . Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.  Hepatology. 2003;  38 1043-1050
    CrossrefPubMedGoogle Scholar
  • 16 Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L. et al . Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.  Hepatology. 2004;  40 793-801
    CrossrefPubMedGoogle Scholar
  • 17 Primignani M, Carpinelli L, Preatoni P. et al . Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC).  Gastroenterology. 2000;  119 181-187
    CrossrefPubMedGoogle Scholar
  • 18 Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.  Hepatology. 1992;  16 1343-1349
    CrossrefPubMedGoogle Scholar
  • 19 Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.  Aliment Pharmacol Ther. 2005;  21 525-529
    CrossrefPubMedGoogle Scholar
  • 20 Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites.  N Engl J Med. 2004;  350 1646-1654
    CrossrefPubMedGoogle Scholar
  • 21 Rimola A, Garcia-Tsao G, Navasa M. et al . Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.  J Hepatol. 2000;  32 142-153
    PubMedGoogle Scholar
  • 22 Sort P, Navasa M, Arroyo V. et al . Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.  N Engl J Med. 1999;  341 403-409
    CrossrefPubMedGoogle Scholar

M. Peck-Radosavljevic, M. D.

Abteilung für Gastroenterologie und Hepatologie, Klinik Innere Medizin IV

Medizinische Universität Wien · Währinger Gürtel 18 - 20 · A-1090 Wien

Phone: +43-1-40400-6589 ·

Fax: +43-1-40400-4735

Email: Markus.peck@meduniwien.ac.at

      >